Current:Home > MarketsBank of England will review the risks that AI poses to UK financial stability -Golden Summit Finance
Bank of England will review the risks that AI poses to UK financial stability
View
Date:2025-04-15 17:55:40
LONDON (AP) — The Bank of England, which oversees financial stability in the U.K., said Wednesday that it will make an assessment next year about the risks posed by artificial intelligence and machine learning.
In its half-yearly Financial Stability Review, the bank said it was getting advice about the potential implications stemming from the adoption of AI and machine learning in the financial services sector, which accounts for around 8% of the British economy and has deep-rooted global connections.
The bank’s Financial Policy Committee, which identifies and monitors risks, said it and other authorities would seek to ensure that the U.K. financial system is resilient to risks that may arise from widespread use of AI and machine learning.
“We obviously have to go into AI with our eyes open,” bank Gov. Andrew Bailey said at a press briefing. “It is something that I think we have to embrace, it is very important and has potentially profound implications for economic growth, productivity and how economies are shaped going forward.”
Over the past year, the potential benefits and threats of the new technologies have grown. Some observers have raised concerns over AI’s as-yet-unknown dangers and have been calling for safeguards to protect people from its existential threats.
There is a global race to figure out how to regulate AI as OpenAI’s ChatGPT and other chatbots exploded in popularity, with their ability to create human-like text and images. Leaders in the 27-nation European Union on Wednesday are trying to agree on world-first AI regulations.
“The moral of the story is if you’re a firm using AI, you have to understand the tool you are using, that is the critical thing,” Bailey said.
Admitting that he is “palpably not” an expert on AI, Bailey said the new technologies have “tremendous potential” and are not simply “a bag of risks.”
veryGood! (25745)
Related
- Stamford Road collision sends motorcyclist flying; driver arrested
- Don't Let These 60% Off Good American Deals Sell Out Before You Can Add Them to Your Cart
- Rob Lowe Celebrates 33 Years of Sobriety With Message on His Recovery Journey
- Cracker Barrel faces boycott call for celebrating Pride Month
- Google unveils a quantum chip. Could it help unlock the universe's deepest secrets?
- Coach Outlet's New Y2K Shop Has 70% Off Deals on Retro-Inspired Styles
- How a cup of coffee from a gym owner changed a homeless man's life
- Why China's 'zero COVID' policy is finally faltering
- Cincinnati Bengals quarterback Joe Burrow owns a $3 million Batmobile Tumbler
- Natalee Holloway Disappearance Case: Suspect Joran van der Sloot to Be Extradited to the U.S.
Ranking
- Trump suggestion that Egypt, Jordan absorb Palestinians from Gaza draws rejections, confusion
- Timeline: The government's efforts to get sensitive documents back from Trump's Mar-a-Lago
- Mama June Shannon Reveals She Spent $1 Million on Drugs Amid Addiction
- An art exhibit on the National Mall honors health care workers who died of COVID
- New Zealand official reverses visa refusal for US conservative influencer Candace Owens
- Rhode Island Sues Oil Companies Over Climate Change, First State in Wave of Lawsuits
- Hidden audits reveal millions in overcharges by Medicare Advantage plans
- Today’s Climate: September 2, 2010
Recommendation
Man can't find second winning lottery ticket, sues over $394 million jackpot, lawsuit says
NYC Mayor Adams faces backlash for move to involuntarily hospitalize homeless people
Hidden audits reveal millions in overcharges by Medicare Advantage plans
‘This Was Preventable’: Football Heat Deaths and the Rising Temperature
2025 'Doomsday Clock': This is how close we are to self
How some therapists are helping patients heal by tackling structural racism
When COVID closed India, these women opened their hearts — and wallets
Is lecanemab the Alzheimer's drug that will finally make a difference?